# Madrigal Pharmaceuticals, Inc. (MDGL) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $958M |
| 2024 | $180M |
| 2023 | — |
| 2022 | — |
| 2021 | — |
| 2020 | — |
| 2019 | — |
| 2018 | — |
| 2017 | — |
| 2012 | $147,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $311M |
| 2025-09-30 | $287M |
| 2025-06-30 | $213M |
| 2025-03-31 | $137M |
| 2024-09-30 | $62M |
| 2024-06-30 | $15M |
| 2024-03-31 | — |
| 2023-09-30 | — |
| 2023-06-30 | — |
| 2023-03-31 | — |
| 2022-03-31 | — |
| 2021-09-30 | — |
| 2021-06-30 | — |
| 2021-03-31 | — |
| 2020-09-30 | — |
| 2020-06-30 | — |
| 2020-03-31 | — |
| 2019-09-30 | — |
| 2019-06-30 | — |
| 2019-03-31 | — |
| 2018-03-31 | — |

Source: [CompaniesByCap](https://companiesbycap.com/company/MDGL/revenue)